According to Stratistics MRC, the Global Active Implantable Medical Devices market is accounted for $19.40 billion in 2017 and is expected to reach $43.25 billion by 2026 growing at a CAGR of 9.3% during the forecast period. Some of the factors like increasing demand for technological advanced products, growing demand for neurostimulators are the factors that are fuelling the market growth. In addition, growing number of patients with cardiovascular disease and neurological disorders is also one of the favouring factor for the market growth. However, failure of device, high cost of implants and infection at surgical site are hindering the market.

Active Implantable Medical Devices are the devices which are partially or totally introduced into human body either surgically or medically. On the basis of product, implantable cardioverter defibrillators (ICD) held the largest market share and expected to remain the same during the forecast period by surpassing other products and also due to increasing prevalence of cardiovascular diseases. In terms of end users, hospital sector is the bench topper among all due to the infrastructural development and increasing demand of medical devices.

By Geography, North America dominates other regions due to the growing demand of novel active implantable devices and expected to retain its position over the next few years followed by Asia pacific and Europe.